DECOR Information for Project: CDA-CH-VACD - Immunization Content (eVACDOC) (cdachvacd-)

Templates

HTML Name Effective Date Version Label
Templates with direct association to a transaction
html pending Immunization Administration 2.16.756.5.30.1.1.10.1.16 2018‑04‑19 2018
Swiss eVACDOC - Immunization Administration
Transaction Direction Underlying Model Schematron
CDA-CH-VACD - Immunization Administration arrowright initial ClinicalDocument cdachvacd-Administration.sch
html pending Immunization Certificate 2.16.756.5.30.1.1.10.1.15 2018‑04‑19 2018
Swiss eVACDOC - Immunization Certificate
Transaction Direction Underlying Model Schematron
CDA-CH-VACD - Immunization Certificate arrowright initial ClinicalDocument cdachvacd-Certificate.sch
html pending Immunization Recommendation Request 2.16.756.5.30.1.1.10.1.17 2018‑04‑19 2018
Swiss eVACDOC - Immunization Recommendation Request
Transaction Direction Underlying Model Schematron
CDA-CH-VACD - Immunization Recommendation Request arrowright initial ClinicalDocument cdachvacd-RecommendationRequest.sch
html pending Immunization Recommendation Response 2.16.756.5.30.1.1.10.1.18 2018‑04‑19 2018
Swiss eVACDOC - Immunization Recommendation Response
Transaction Direction Underlying Model Schematron
CDA-CH-VACD - Immunization Recommendation Response arrowright initial ClinicalDocument cdachvacd-RecommendationResponse.sch
html pending Vaccination Record 2.16.756.5.30.1.1.10.1.19 2018‑04‑19 2018
Swiss eVACDOC - Vaccination Record
Transaction Direction Underlying Model Schematron
CDA-CH-VACD - Vaccination Record arrowright initial ClinicalDocument cdachvacd-VaccinationRecord.sch
CDA Header Level Template
html ref Authenticator 2.16.756.5.30.1.1.10.2.6
ref
hl7chcda-
 		2018‑04‑18 2017
Information about an authenticator of a CDA document. An authenticator MUST be a person. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST use this template by either reference or specialisa...
html ref Custodian 2.16.756.5.30.1.1.10.2.3
ref
hl7chcda-
 		2018‑04‑18 2017
The organization in whose name this CDA document has been created (corresponds to the sender of a letter). All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST use this template by either refer...
html ref Data Enterer 2.16.756.5.30.1.1.10.2.7
ref
hl7chcda-
 		2018‑04‑18 2017
Information about the person that entered information in this CDA document. It SHALL be declared, when data recorded in this document has been entered by a person other than the author but only when t...
html pending Document Code 2.16.756.5.30.1.1.10.2.63 2018‑04‑19 2018
A LOINC based document type of a CDA document instance including a translation to the Swiss EPR XDS.b metadata. The LOINC code of the document MUST read: 11369-6 (H...
html ref Document Confidentiality Code 2.16.756.5.30.1.1.10.2.19
ref
hl7chcda-
 		2018‑04‑18 2017
A confidentiality level of a CDA document instance according to the Swiss EPR regulation. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST reference this template. Langu...
html ref Document Language 2.16.756.5.30.1.1.10.2.22
ref
hl7chcda-
 		2018‑04‑18 2017
The RFC 1766 (ISO-639-1 and ISO 3166) based language in which the narrative texts in this CDA document instance are written. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST reference this ...
html ref Document Realm 2.16.756.5.30.1.1.10.2.25
ref
hl7chcda-
 		2018‑04‑18 2017
Swiss Realm (CHE) of HL7 CDA. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST reference this template.
html ref Document Replacement - relatedDocument 2.16.756.5.30.1.1.10.2.13
ref
hl7chcda-
 		2018‑04‑18 2017
Relationship to another CDA-CH V2 based document that is replaced by the current one. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST reference this template.
html ref Document Set Id and Version Number 2.16.756.5.30.1.1.10.2.20
ref
hl7chcda-
 		2018‑04‑18 2017
Unity of document versions. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST reference this template.
html ref Document Template Ids CDA-CH v2.0 - structuredBody 2.16.756.5.30.1.1.10.2.18
ref
hl7chcda-
 		2018‑04‑18 2017
CDA-CH V2 bases on HL7 CDA R2 (2005) and - by using this template - require a structured body. All CDA-CH V2 derivatives, i.e. Swiss exchange formats SHALL reference this template. These SHALL define...
html pending Document Template Ids CDA-CH-VACD V2 for Swiss EPR 2.16.756.5.30.1.1.10.2.67 2018‑04‑19 2018
CDA-CH-VACD V2 bases on CDA-CH V2 (2017) and the Immunization Content profile (IHE PCC TF 11.0, 2016). This template defines the rules for documents to be published in the Swiss EPR.
html pending Document Template Ids CDA-CH-VACD V2 non Swiss EPR 2.16.756.5.30.1.1.10.2.71 2018‑04‑19 2018
CDA-CH-VACD V2 bases on CDA-CH V2 (2017) and the Immunization Content profile (IHE PCC TF 11.0, 2016). This template defines the rules for documents that are not to be published in the Swiss EPR.
html ref Health Service - documentationOf 2.16.756.5.30.1.1.10.2.46
ref
hl7chcda-
 		2018‑04‑18 2017
Information about a health service describing the context of this CDA document. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST use this template by either reference or specialisation.
html pending Human Patient - recordTarget 2.16.756.5.30.1.1.10.2.68 2018‑04‑19 2018
A human patient for whom this CDA document instance was created.
html ref Insurance - participant 2.16.756.5.30.1.1.10.2.15
ref
hl7chcda-
 		2018‑04‑18 2017
Information on a patient's insurance. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specialisation.
html ref Insurance Card - participant 2.16.756.5.30.1.1.10.2.14
ref
hl7chcda-
 		2018‑04‑18 2017
Information on a patient's insurance card. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specialisation.
html ref Legal Authenticator 2.16.756.5.30.1.1.10.2.5
ref
hl7chcda-
 		2018‑04‑18 2017
Information about the legal authenticator of a CDA document. A legal authenticator MUST be a person. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST use this template by either reference o...
html pending Masked Patient - recordTarget 2.16.756.5.30.1.1.10.2.69 2018‑04‑19 2018
A human patient for whom this CDA document instance was created. Its demographic data is masked as much as possible. Only the demographic information (such as gender, birthdate and city) that is neede...
html ref Order Reference - inFulfillmentOf 2.16.756.5.30.1.1.10.2.16
ref
hl7chcda-
 		2018‑04‑18 2017
Reference to one or more orders which led to the creation of this CDA document. It SHALL be declared, when the order reference is relevant for some reason. All CDA-CH V2 derivatives, i.e. Swiss exchan...
html ref Recipient - informationRecipient 2.16.756.5.30.1.1.10.2.4
ref
hl7chcda-
 		2018‑04‑18 2017
A recipient of this CDA document (corresponds to the addressee of a letter - person or organization). All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST use this template by either reference ...
CDA Section Level Template
html ref Active Problems Section - coded 2.16.756.5.30.1.1.10.3.25
ref
ch-pcc-
 		2016‑11‑11 2016
Chapter (CDA Body Section) containing the active problem list according to IHE PCC Technical Framework Revision 11.0 - November 11, 2016. This section MAY contain t...
html ref Allergies and other Adverse Reactions Section - coded 2.16.756.5.30.1.1.10.3.51
ref
ch-pcc-
 		2016‑11‑11 2016
Chapter (CDA Body Section) containing allergies and other adverse reactions according to IHE PCC Technical Framework Revision 11.0 - November 11, 2016. This section...
html ref Current Pregnancy Section - coded 2.16.756.5.30.1.1.10.3.53
ref
ch-pcc-
 		2018‑04‑19 2018
Chapter (CDA Body Section) containing the information about a current pregnancy. This section is specialisation of the Pregnancy Hostory section according to IHE PCC Technical Framew...
html ref History Of Past Illness Section - coded 2.16.756.5.30.1.1.10.3.50
ref
ch-pcc-
 		2016‑11‑11 2016
Chapter (CDA Body Section) containing the history of past illness according to IHE PCC Technical Framework Revision 11.0 - November 11, 2016. This section contains ...
html ref Immunization Recommendations Section - coded 2.16.756.5.30.1.1.10.3.48
ref
ch-pcc-
 		2016‑11‑11 2016
Chapter (CDA Body Section) containing immunization recommendations according to IHE PCC Technical Framework Revision 11.0 - November 11, 2016. This section MAY cont...
html ref Immunizations Section - coded 2.16.756.5.30.1.1.10.3.47
ref
ch-pcc-
 		2016‑11‑11 2016
Chapter (CDA Body Section) containing immunizations according to IHE PCC Technical Framework Revision 11.0 - November 11, 2016. This section contains administered i...
html ref Laboratory Report Item Section - coded 2.16.756.5.30.1.1.10.3.5
ref
ch-palm-
 		2017‑06‑21 2017
A Laboratory Specialty Section SHALL contain EITHER a list of Laboratory Report Item Section(s) OR a single text and entry element to represent the Report Items. ...
html ref Laboratory Speciality Section - coded 2.16.756.5.30.1.1.10.3.3
ref
ch-palm-
 		2017‑06‑21 2017
Chapter (CDA Body Section) with laboratory results according to Sharing Laboratory Reports (XD-LAB) Content Module, IHE PaLM Technical Framework Revision 8.0 - June 21, 2017. Each Laboratory Special...
html pending Other Relevant Observations Section - coded 2.16.756.5.30.1.1.10.3.46 2018‑04‑19 2018
Chapter (CDA Body Section) containing the coded results according to IHE PCC Technical Framework Revision 11.0 - November 11, 2016. This section MAY contain relevan...
html ref Remarks Section - coded 2.16.756.5.30.1.1.10.3.2
ref
hl7chcda-
 		2018‑04‑18 2017
This section MAY be used to provide comments, remarks or other information that cannot be declared in any of the other existing sections in the document.
CDA Entry Level Template
html ref Allergies and Intolerances Concern Entry 2.16.756.5.30.1.1.10.4.91
ref
ch-pcc-
 		2016‑11‑11 2016
This element is a specialization of 'Problem Concern' whereby the problem is focused on an allergy or intolerance. It therefore describes an allergy or intolerances...
html ref Allergy Or Intolerance Entry 2.16.756.5.30.1.1.10.4.98
ref
ch-pcc-
 		2016‑11‑11 2016
Allergies or intolerances are a special form of a 'Problem Entry'. In relation with immunizations, substances in vaccines SHALL be recorded here, using the WHO ATC ...
html ref Annotation Comments 2.16.756.5.30.1.1.10.4.2
ref
ch-pcc-
 		2016‑11‑11 2016
This entry allows for a comment to be supplied with each entry.
html ref Case Identification 2.16.756.5.30.1.1.10.4.15
ref
ch-palm-
 		2017‑06‑21 2017
If an examination belongs to a specific case, this CAN be documented with this element (in the Notification Organizer).
html ref Device - participant Containment 2.16.756.5.30.1.1.10.4.10
ref
ch-palm-
 		2017‑06‑21 2017
Declaration of analyzer, test kit and manufacturer used to determine the result. All participating elements (including devices), MUST according to XD-LAB contain name, addr and telecom.
html ref External document 2.16.756.5.30.1.1.10.4.29
ref
hl7chcda-
 		2018‑04‑18 2017
External documents can be included in a CDA document, either by means of references or by means of XML embedding. This template defines a reference to an external document, only. Embedded documents...
html pending Gestational Age At Birth 2.16.756.5.30.1.1.10.4.84 2018‑04‑19 2018
The coded gestational age in days of gestation at birth of a patient. This item is intended to be applied for the child but not for the mother.
html ref Human Patient with Non-Human Subject - subject Containment 2.16.756.5.30.1.1.10.4.6
ref
ch-palm-
 		2017‑06‑21 2017
If, in a part of the document, certain laboratory observations for a human patient base on a sample of a non-human material (e.g., food eaten by the patient or an animal that has bitten the patient), ...
html ref Immunization Entry 2.16.756.5.30.1.1.10.4.89
ref
ch-pcc-
 		2016‑11‑11 2016
An immunizations entry is used to record the patient's immunization history. An immunization is a substance administration event. An immunization entry may also be used to report a specific immunizati...
html ref Immunization Performer - performer Containment 2.16.756.5.30.1.1.10.4.101
ref
ch-pcc-
 		2016‑11‑11 2016
Health professional that administered the immunization.
html ref Immunization Recommendation Entry 2.16.756.5.30.1.1.10.4.93
ref
ch-pcc-
 		2016‑11‑11 2016
An immunization recommendation entry is used to record the patient's immunization plan. An immunization recommendation is a substance administration proposal or a documentation of an intended, but not...
html ref Laboratory Battery Organizer 2.16.756.5.30.1.1.10.4.19
ref
ch-palm-
 		2017‑06‑21 2017
According to IHE XD-LAB, the Laboratory Battery Organizer allows the grouping of results. Laboratory reports MUST contain at least one result group with at least one result. The grouping of multipl...
html ref Laboratory Isolate Organizer 2.16.756.5.30.1.1.10.4.17
ref
ch-palm-
 		2017‑06‑21 2017
The Laboratory Isolate Organizer MUST ONLY be used if it is a microbiological specimen with which isolates/germs were examined.
html ref Laboratory Observation 2.16.756.5.30.1.1.10.4.3
ref
ch-palm-
 		2017‑06‑21 2017
Laboratory reports MUST contain at least one laboratory result which is declared using this element. Each laboratory result consists of code, value and interpretation of the result. ...
html ref Laboratory Performer - performer Containment 2.16.756.5.30.1.1.10.4.7
ref
ch-palm-
 		2017‑06‑21 2017
This CAN be used to indicate another executing laboratory in the CDA body. When executing laboratories are specified, the following applies: If all tests have...
html ref Laboratory Report Data Processing Entry 2.16.756.5.30.1.1.10.4.4
ref
ch-palm-
 		2017‑06‑21 2017
Each chapter (Laboratory Speciality Section and Laboratory Report Item Section) MUST contain exactly one findings group (CDA Body Laboratory Report Data Processing Entry).
html ref Laboratory Results Validator - authenticator/participant Containment 2.16.756.5.30.1.1.10.4.8
ref
ch-palm-
 		2017‑06‑21 2017
The document MAY contain further signatures (besides the legal authenticator). A Laboratory Results Validator is such an authenticator. It is a laboratory specialist who has performe...
html ref Manufactured Product 2.16.756.5.30.1.1.10.4.94
ref
ch-pcc-
 		2016‑11‑11 2016
Structured information on a product (e.g. Vaccine or Medication). Trade name of the product SHALL be present in the element 'name' of manufact...
html ref Multimedia Embedded Content 2.16.756.5.30.1.1.10.4.18
ref
ch-palm-
 		2017‑06‑21 2017
Multimedia objects (e.g., PDF representations of the CDA document, pictures, Reiber diagrams, electrophoresis, etc.) MAY be integrated into a CDA document, either by reference to ext...
html ref Non-Human Subject - subject Containment 2.16.756.5.30.1.1.10.4.5
ref
ch-palm-
 		2017‑06‑21 2017
If, in a part of the document, laboratory obseravtions base exclusively on a sample of a non-human material (e.g., animal, water, soil, etc.) without reference to a patient, it MUST be declared using...
html ref Notifiable Condition 2.16.756.5.30.1.1.10.4.14
ref
ch-palm-
 		2017‑06‑21 2017
If a reportable condition is given (e.g., according to the Federal Act on Combating Communicable Human Diseases and the associated ordinance), this CAN be declared in the CDA body using this element.
html ref Notification Organizer 2.16.756.5.30.1.1.10.4.13
ref
ch-palm-
 		2017‑06‑21 2017
A laboratory report MAY contain information on the obligation to report pathogen detection, on accumulation of observations or specific epidemiologically relevant events. ...
html ref Outbreak Identification 2.16.756.5.30.1.1.10.4.16
ref
ch-palm-
 		2017‑06‑21 2017
If an examination falls under the category "accumulation of observations" or "specific epidemiologically relevant event", this CAN be declared in the CDA body using this element. ...
html ref Pregnancy Observation Delivery Date 2.16.756.5.30.1.1.10.4.102
ref
ch-pcc-
 		2018‑04‑19 2018
This element contains structured information about the delivery date of a pregnancy.
html ref Pregnancy Observation Entry 2.16.756.5.30.1.1.10.4.92
ref
ch-pcc-
 		2016‑11‑11 2016
This element contains structured information about a pregnancy.
html ref Previous Observation 2.16.756.5.30.1.1.10.4.22
ref
ch-palm-
 		2017‑06‑21 2017
A laboratory result can be supplemented with any number of previous results, if this information is important. Previous laboratory results MUST be associated to the same patient, the same test, the sa...
html ref Problem Concern Entry 2.16.756.5.30.1.1.10.4.90
ref
ch-pcc-
 		2016‑11‑11 2016
This element describes a problem concern of the patient and indicates the period of time where this concern is active. It contains a set of references to problems related to this concern. In the conte...
html ref Problem Entry 2.16.756.5.30.1.1.10.4.97
ref
ch-pcc-
 		2016‑11‑11 2016
Problem as structured entry (e.g. syptom, complaint, diagnosis etc.)
html ref Problem Status Observation 2.16.756.5.30.1.1.10.4.100
ref
ch-pcc-
 		2016‑11‑11 2016
Any problem or allergy observation may reference a problem status observation.
html ref Recommendation Category - Criterion 2.16.756.5.30.1.1.10.4.96
ref
ch-pcc-
 		2018‑04‑19 2018
Recommendation category according to the Swiss vaccination plan.
html ref Responsible Party - participant Containment 2.16.756.5.30.1.1.10.4.9
ref
ch-palm-
 		2017‑06‑21 2017
External laboratory that has delivered the results. The following applies: The external laboratory MUST be declared, including its responsible person. All...
html ref Severity Entry 2.16.756.5.30.1.1.10.4.99
ref
ch-pcc-
 		2016‑11‑11 2016
Declaration of the severity of a problem or an allergy/intolerance
html ref Specimen Collection 2.16.756.5.30.1.1.10.4.11
ref
ch-palm-
 		2017‑06‑21 2017
Laboratory reports MAY contain information on the specimen. If there are more than one specimen associated to the order, then this item occurs multiple times.
html ref Specimen collection - participant Containment 2.16.756.5.30.1.1.10.4.24
ref
ch-palm-
 		2017‑06‑21 2017
Specimen Information.
html ref Specimen Received 2.16.756.5.30.1.1.10.4.12
ref
ch-palm-
 		2017‑06‑21 2017
A laboratory report MAY contain information on the reception of the specimen at the laboratory.
html ref Specimen Type 2.16.756.5.30.1.1.10.4.27
ref
ch-palm-
 		2017‑06‑21 2017
Specimen Type.
html ref Target Of The Immunization - Medication Target 2.16.756.5.30.1.1.10.4.95
ref
ch-pcc-
 		2018‑04‑19 2018
Target of the immunization. All immunizations targets (diseases) SHALL be recorded with an immunization entry. This element allows structured information for immunizations with combinded vaccines (e.g...
Template type not specified
html ref Address Information Compilation - eCH-0010 2.16.756.5.30.1.1.10.9.35
ref
hl7chcda-
 		2018‑04‑18 2017
Address information according to the eCH-0010 V7.0 addressInformation data type. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specialisation. See h...
html ref Assigned Entity Compilation with GLN and name 2.16.756.5.30.1.1.10.9.51
ref
hl7chcda-
 		2018‑04‑18 2017
Reusable template wherever an assigned entity with a required GLN is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or speci...
html ref Assigned Entity Compilation with GLN, name, addr, telecom, person and organization 2.16.756.5.30.1.1.10.9.50
ref
hl7chcda-
 		2018‑04‑18 2017
Reusable template wherever an assigned entity with required GLN, name, addr, telecom, person and organization (also with GLN) are used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchan...
html ref Assigned Entity Compilation with id 2.16.756.5.30.1.1.10.9.12
ref
hl7chcda-
 		2018‑04‑18 2017
Reusable template wherever an assigned entity with a required id is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specia...
html ref Assigned Entity Compilation with id, name, addr, telecom, person and organization 2.16.756.5.30.1.1.10.9.32
ref
hl7chcda-
 		2018‑04‑18 2017
Reusable template wherever an assigned entity with required id, name, addr, telecom, person and organization are used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY us...
html ref Assigned Entity Compilation with name, addr and telecom 2.16.756.5.30.1.1.10.9.17
ref
hl7chcda-
 		2018‑04‑18 2017
Reusable template wherever an assigned entity with required name, addr and telecom is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either r...
html ref Author 2.16.756.5.30.1.1.10.9.23
ref
hl7chcda-
 		2018‑04‑18 2017
Information about the author of a CDA document, section or entry. An author MAY be a person or a device. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST use this template at least in the C...
html ref Author Compilation with name 2.16.756.5.30.1.1.10.9.48
ref
hl7chcda-
 		2018‑04‑18 2017
Reusable template wherever an author with required name is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specialisation.
html ref Author Compilation with name, addr and telecom 2.16.756.5.30.1.1.10.9.16
ref
hl7chcda-
 		2018‑04‑18 2017
Reusable template wherever an author with required name, addr and telecom is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference ...
html ref Device Compilation with name 2.16.756.5.30.1.1.10.9.21
ref
hl7chcda-
 		2018‑04‑18 2017
Reusable template wherever a device with required name is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specialisation....
html ref Narrative Text Reference 2.16.756.5.30.1.1.10.9.14
ref
hl7chcda-
 		2018‑04‑18 2017
Reusable template wherever a text reference to the corresponding text in the human readable part (narrative text) is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MA...
html ref Organization Compilation with GLN and name 2.16.756.5.30.1.1.10.9.30
ref
hl7chcda-
 		2018‑04‑18 2017
Reusable template wherever an organization with required GLN as id and name is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either referenc...
html ref Organization Compilation with GLN, name, addr and telecom 2.16.756.5.30.1.1.10.9.26
ref
hl7chcda-
 		2018‑04‑18 2017
Reusable template wherever an organization with required GLN as id, name, address and communication means is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use th...
html ref Organization Compilation with id, name, addr and telecom 2.16.756.5.30.1.1.10.9.33
ref
hl7chcda-
 		2018‑04‑18 2017
Reusable template wherever an organization with required id, name, address and communication means is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this temp...
html ref Organization Compilation with name 2.16.756.5.30.1.1.10.9.24
ref
hl7chcda-
 		2018‑04‑18 2017
Reusable template wherever an organization with required name is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specialis...
html ref Organization Compilation with name, addr, telecom 2.16.756.5.30.1.1.10.9.27
ref
hl7chcda-
 		2018‑04‑18 2017
Reusable template wherever an organization with required name, address and communication means is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template...
html ref Original Text Reference 2.16.756.5.30.1.1.10.9.49
ref
hl7chcda-
 		2018‑04‑18 2017
Reusable template wherever a original text reference to the corresponding text in the human readable part (narrative text) is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange f...
html ref Performer 2.16.756.5.30.1.1.10.9.31
ref
hl7chcda-
 		2018‑04‑18 2017
Reusable template wherever a healthcare provider who was the primary performer of an act is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by ei...
html ref Person Name Information Compilation - eCH-0011 2.16.756.5.30.1.1.10.9.34
ref
hl7chcda-
 		2018‑04‑18 2017
Person name information (with required family and given name) according to the eCH-0011 V8.1 nameData data type. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either ref...
html ref PlayingEntity Compilation with name 2.16.756.5.30.1.1.10.9.20
ref
hl7chcda-
 		2018‑04‑18 2017
Reusable template wherever a playing entity with a required name is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specia...

Template Summary

Templates 92

Templates per Scenario

Templates for scenario CDA-CH-VACD cdachvacd-3 as of 2015‑12‑11

Transaction Representing template Link as of
CDA-CH-VACD - Immunization Administration 2.16.756.5.30.1.1.10.1.16 Immunization Administration 2018‑04‑19
CDA-CH-VACD - Immunization Certificate 2.16.756.5.30.1.1.10.1.15 Immunization Certificate 2018‑04‑19
CDA-CH-VACD - Immunization Recommendation Request 2.16.756.5.30.1.1.10.1.17 Immunization Recommendation Request 2018‑04‑19
CDA-CH-VACD - Immunization Recommendation Response 2.16.756.5.30.1.1.10.1.18 Immunization Recommendation Response 2018‑04‑19
CDA-CH-VACD - Vaccination Record 2.16.756.5.30.1.1.10.1.19 Vaccination Record 2018‑04‑19

Item Labels per Template

Label Template id Template name Link as of
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.13 Document Replacement - relatedDocument 2.16.756.5.30.1.1.10.2.13 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.14 Insurance Card - participant 2.16.756.5.30.1.1.10.2.14 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.15 Insurance - participant 2.16.756.5.30.1.1.10.2.15 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.16 Order Reference - inFulfillmentOf 2.16.756.5.30.1.1.10.2.16 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.18 Document Template Ids CDA-CH v2.0 - structuredBody 2.16.756.5.30.1.1.10.2.18 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.19 Document Confidentiality Code 2.16.756.5.30.1.1.10.2.19 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.20 Document Set Id and Version Number 2.16.756.5.30.1.1.10.2.20 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.22 Document Language 2.16.756.5.30.1.1.10.2.22 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.25 Document Realm 2.16.756.5.30.1.1.10.2.25 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.3 Custodian 2.16.756.5.30.1.1.10.2.3 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.4 Recipient - informationRecipient 2.16.756.5.30.1.1.10.2.4 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.46 Health Service - documentationOf 2.16.756.5.30.1.1.10.2.46 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.5 Legal Authenticator 2.16.756.5.30.1.1.10.2.5 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.6 Authenticator 2.16.756.5.30.1.1.10.2.6 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.7 Data Enterer 2.16.756.5.30.1.1.10.2.7 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.3.2 Remarks Section - coded 2.16.756.5.30.1.1.10.3.2 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.4.29 External document 2.16.756.5.30.1.1.10.4.29 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.12 Assigned Entity Compilation with id 2.16.756.5.30.1.1.10.9.12 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.14 Narrative Text Reference 2.16.756.5.30.1.1.10.9.14 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.16 Author Compilation with name, addr and telecom 2.16.756.5.30.1.1.10.9.16 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.17 Assigned Entity Compilation with name, addr and telecom 2.16.756.5.30.1.1.10.9.17 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.20 PlayingEntity Compilation with name 2.16.756.5.30.1.1.10.9.20 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.21 Device Compilation with name 2.16.756.5.30.1.1.10.9.21 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.23 Author 2.16.756.5.30.1.1.10.9.23 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.24 Organization Compilation with name 2.16.756.5.30.1.1.10.9.24 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.26 Organization Compilation with GLN, name, addr and telecom 2.16.756.5.30.1.1.10.9.26 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.27 Organization Compilation with name, addr, telecom 2.16.756.5.30.1.1.10.9.27 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.30 Organization Compilation with GLN and name 2.16.756.5.30.1.1.10.9.30 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.32 Assigned Entity Compilation with id, name, addr, telecom, person and organization 2.16.756.5.30.1.1.10.9.32 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.33 Organization Compilation with id, name, addr and telecom 2.16.756.5.30.1.1.10.9.33 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.48 Author Compilation with name 2.16.756.5.30.1.1.10.9.48 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.49 Original Text Reference 2.16.756.5.30.1.1.10.9.49 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.50 Assigned Entity Compilation with GLN, name, addr, telecom, person and organization 2.16.756.5.30.1.1.10.9.50 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.51 Assigned Entity Compilation with GLN and name 2.16.756.5.30.1.1.10.9.51 2018‑04‑18
CDA‑CH V2 Body Templates link11 2.16.756.5.30.1.1.10.3.53 Current Pregnancy Section - coded 2.16.756.5.30.1.1.10.3.53 2018‑04‑19
CDA‑CH‑VACD link11 2.16.756.5.30.1.1.10.2.67 Document Template Ids CDA-CH-VACD V2 for Swiss EPR 2.16.756.5.30.1.1.10.2.67 2018‑04‑19
CDA‑CH‑VACD link11 2.16.756.5.30.1.1.10.2.68 Human Patient - recordTarget 2.16.756.5.30.1.1.10.2.68 2018‑04‑19
CDA‑CH‑VACD link11 2.16.756.5.30.1.1.10.2.69 Masked Patient - recordTarget 2.16.756.5.30.1.1.10.2.69 2018‑04‑19
CDA‑CH‑VACD link11 2.16.756.5.30.1.1.10.2.71 Document Template Ids CDA-CH-VACD V2 non Swiss EPR 2.16.756.5.30.1.1.10.2.71 2018‑04‑19
CDA‑CH‑VACD link11 2.16.756.5.30.1.1.10.4.101 Immunization Performer - performer Containment 2.16.756.5.30.1.1.10.4.101 2016‑11‑11
CDA‑CH‑VACD link11 2.16.756.5.30.1.1.10.4.95 Target Of The Immunization - Medication Target 2.16.756.5.30.1.1.10.4.95 2018‑04‑19
CDA‑CH‑VACD link11 2.16.756.5.30.1.1.10.4.96 Recommendation Category - Criterion 2.16.756.5.30.1.1.10.4.96 2018‑04‑19
CH‑PALM link11 2.16.756.5.30.1.1.10.4.10 Device - participant Containment 2.16.756.5.30.1.1.10.4.10 2017‑06‑21
CH‑PALM link11 2.16.756.5.30.1.1.10.4.18 Multimedia Embedded Content 2.16.756.5.30.1.1.10.4.18 2017‑06‑21
CH‑PALM link11 2.16.756.5.30.1.1.10.4.27 Specimen Type 2.16.756.5.30.1.1.10.4.27 2017‑06‑21
CH‑PCC link11 2.16.756.5.30.1.1.10.4.102 Pregnancy Observation Delivery Date 2.16.756.5.30.1.1.10.4.102 2018‑04‑19
CH‑PCC link11 2.16.756.5.30.1.1.10.4.84 Gestational Age At Birth 2.16.756.5.30.1.1.10.4.84 2018‑04‑19
IHE PCC TF2 Rev.11, 6.3.1.10.1 link11 2.16.756.5.30.1.1.10.2.63 Document Code 2.16.756.5.30.1.1.10.2.63 2018‑04‑19
IHE PCC TF2 Rev.11, 6.3.3.2.11 link11 2.16.756.5.30.1.1.10.3.51 Allergies and other Adverse Reactions Section - coded 2.16.756.5.30.1.1.10.3.51 2016‑11‑11
IHE PCC TF2 Rev.11, 6.3.3.2.3 link11 2.16.756.5.30.1.1.10.3.25 Active Problems Section - coded 2.16.756.5.30.1.1.10.3.25 2016‑11‑11
IHE PCC TF2 Rev.11, 6.3.3.2.5 link11 2.16.756.5.30.1.1.10.3.50 History Of Past Illness Section - coded 2.16.756.5.30.1.1.10.3.50 2016‑11‑11
IHE PCC TF2 Rev.11, 6.3.3.3.5 link11 2.16.756.5.30.1.1.10.3.47 Immunizations Section - coded 2.16.756.5.30.1.1.10.3.47 2016‑11‑11
IHE PCC TF2 Rev.11, 6.3.3.5.2 link11 2.16.756.5.30.1.1.10.3.46 Other Relevant Observations Section - coded 2.16.756.5.30.1.1.10.3.46 2018‑04‑19
IHE PCC TF2 Rev.11, 6.3.3.6.13 link11 2.16.756.5.30.1.1.10.3.48 Immunization Recommendations Section - coded 2.16.756.5.30.1.1.10.3.48 2016‑11‑11
IHE PCC TF2 Rev.11, 6.3.4.12 link11 2.16.756.5.30.1.1.10.4.90 Problem Concern Entry 2.16.756.5.30.1.1.10.4.90 2016‑11‑11
IHE PCC TF2 Rev.11, 6.3.4.13 link11 2.16.756.5.30.1.1.10.4.91 Allergies and Intolerances Concern Entry 2.16.756.5.30.1.1.10.4.91 2016‑11‑11
IHE PCC TF2 Rev.11, 6.3.4.14 link11 2.16.756.5.30.1.1.10.4.97 Problem Entry 2.16.756.5.30.1.1.10.4.97 2016‑11‑11
IHE PCC TF2 Rev.11, 6.3.4.15 link11 2.16.756.5.30.1.1.10.4.98 Allergy Or Intolerance Entry 2.16.756.5.30.1.1.10.4.98 2016‑11‑11
IHE PCC TF2 Rev.11, 6.3.4.17 link11 2.16.756.5.30.1.1.10.4.89 Immunization Entry 2.16.756.5.30.1.1.10.4.89 2016‑11‑11
IHE PCC TF2 Rev.11, 6.3.4.19 link11 2.16.756.5.30.1.1.10.4.94 Manufactured Product 2.16.756.5.30.1.1.10.4.94 2016‑11‑11
IHE PCC TF2 Rev.11, 6.3.4.25 link11 2.16.756.5.30.1.1.10.4.92 Pregnancy Observation Entry 2.16.756.5.30.1.1.10.4.92 2016‑11‑11
IHE PCC TF2 Rev.11, 6.3.4.3 link11 2.16.756.5.30.1.1.10.4.99 Severity Entry 2.16.756.5.30.1.1.10.4.99 2016‑11‑11
IHE PCC TF2 Rev.11, 6.3.4.4 link11 2.16.756.5.30.1.1.10.4.100 Problem Status Observation 2.16.756.5.30.1.1.10.4.100 2016‑11‑11
IHE PCC TF2 Rev.11, 6.3.4.49 link11 2.16.756.5.30.1.1.10.4.93 Immunization Recommendation Entry 2.16.756.5.30.1.1.10.4.93 2016‑11‑11
IHE PCC TF2 Rev.11, 6.3.4.6 link11 2.16.756.5.30.1.1.10.4.2 Annotation Comments 2.16.756.5.30.1.1.10.4.2 2016‑11‑11
IHE PalM TF3 Rev.8 link11 2.16.756.5.30.1.1.10.4.9 Responsible Party - participant Containment 2.16.756.5.30.1.1.10.4.9 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.2.16 link11 2.16.756.5.30.1.1.10.4.8 Laboratory Results Validator - authenticator/participant Containment 2.16.756.5.30.1.1.10.4.8 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.2.20 link11 2.16.756.5.30.1.1.10.4.7 Laboratory Performer - performer Containment 2.16.756.5.30.1.1.10.4.7 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.3.1 link11 2.16.756.5.30.1.1.10.3.3 Laboratory Speciality Section - coded 2.16.756.5.30.1.1.10.3.3 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.3.2 link11 2.16.756.5.30.1.1.10.3.5 Laboratory Report Item Section - coded 2.16.756.5.30.1.1.10.3.5 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.4.10 link11 2.16.756.5.30.1.1.10.4.16 Outbreak Identification 2.16.756.5.30.1.1.10.4.16 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.4.11 link11 2.16.756.5.30.1.1.10.4.17 Laboratory Isolate Organizer 2.16.756.5.30.1.1.10.4.17 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.4.12 link11 2.16.756.5.30.1.1.10.4.19 Laboratory Battery Organizer 2.16.756.5.30.1.1.10.4.19 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.4.13 link11 2.16.756.5.30.1.1.10.4.22 Previous Observation 2.16.756.5.30.1.1.10.4.22 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.4.13 link11 2.16.756.5.30.1.1.10.4.3 Laboratory Observation 2.16.756.5.30.1.1.10.4.3 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.4.2 link11 2.16.756.5.30.1.1.10.4.4 Laboratory Report Data Processing Entry 2.16.756.5.30.1.1.10.4.4 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.4.3 link11 2.16.756.5.30.1.1.10.4.5 Non-Human Subject - subject Containment 2.16.756.5.30.1.1.10.4.5 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.4.4 link11 2.16.756.5.30.1.1.10.4.6 Human Patient with Non-Human Subject - subject Containment 2.16.756.5.30.1.1.10.4.6 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.4.5 link11 2.16.756.5.30.1.1.10.4.11 Specimen Collection 2.16.756.5.30.1.1.10.4.11 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.4.5 link11 2.16.756.5.30.1.1.10.4.24 Specimen collection - participant Containment 2.16.756.5.30.1.1.10.4.24 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.4.6 link11 2.16.756.5.30.1.1.10.4.12 Specimen Received 2.16.756.5.30.1.1.10.4.12 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.4.7 link11 2.16.756.5.30.1.1.10.4.13 Notification Organizer 2.16.756.5.30.1.1.10.4.13 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.4.8 link11 2.16.756.5.30.1.1.10.4.14 Notifiable Condition 2.16.756.5.30.1.1.10.4.14 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.4.9 link11 2.16.756.5.30.1.1.10.4.15 Case Identification 2.16.756.5.30.1.1.10.4.15 2017‑06‑21
eCH‑0010 V7.0 addressInformation link11 2.16.756.5.30.1.1.10.9.35 Address Information Compilation - eCH-0010 2.16.756.5.30.1.1.10.9.35 2018‑04‑18
eCH‑0011 V8.1 nameData link11 2.16.756.5.30.1.1.10.9.34 Person Name Information Compilation - eCH-0011 2.16.756.5.30.1.1.10.9.34 2018‑04‑18

Data sets, codes, OIDs and Rules: this information is used for rendering and validation purposes.